Asia Pacific In-Vitro Fertilization Market Growth, Size, Trends, Share, Revenue and Future Outlook

Asia-Pacific In-Vitro Fertilization (IVF) Market Size- By Cycle Type, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Asia-Pacific In-Vitro Fertilization (IVF) Market Size- By Cycle Type, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Published: Feb 2024 Report ID: HLCA2424 Pages: 1 - 154 Formats*:     
Category : Healthcare
Asia-Pacific In-Vitro Fertilization (IVF) Market Introduction and Overview 

According to SPER Market Research, the Asia-Pacific In-Vitro Fertilization (IVF) Market is estimated to reach USD 63.52 Billion by 2033 with a CAGR of 17.24%.

The report includes an in-depth analysis of the Asia-Pacific In-Vitro Fertilization (IVF) Market, including market size and trends, product mix, applications, and supplier analysis. An assisted reproductive technology (ART) process called in vitro fertilisation (IVF) involves fertilising egg cells with sperm outside of the woman's body and then implantation of the resulting embryo(s) into the uterus. This procedure helps with conception by addressing genetic or reproductive problems. It includes the collection of sperm and egg cells, followed by a manual combining process in a lab to create embryos. After that, the uterus receives these embryos to continue their development. IVF is frequently used to help individuals and couples, including LGBT people, single mothers, and those who are struggling with infertility.

  • In March 2020: In order to educate infertile couples about medical advancements, Gurugram Hospital launched a Specialised Infertility Programme and Awareness Campaign. The programme involves sharing IVF success stories with the public, demonstrating how the availability of cutting-edge technology is assisting couples in embracing motherhood.
  • In 2020: Vit Kit-NX is a vitrification medium solution that Fujifilm Irvine Scientific introduced with the goal of protecting embryos and achieving excellent survival rates. Thus, it is projected that the market will develop as a result of an increase in product approvals, product launches, and partnerships for IVF services.
Asia-Pacific In-Vitro Fertilization (IVF) Market
Market Opportunities and Challenges
Rising acceptability of IVF procedures, rising IVF success rates, and rising public knowledge of IVF procedures are the main factors driving the growth of the worldwide Asia-Pacific IVF services market. With further technological advances, the success rate of in vitro fertilisation is increasing. Pre-implantation genetic diagnosis (PGD), intracytoplasmic sperm injection (ICSI), and in vitro maturation (IVM), among other cutting-edge IVF procedures, have contributed to higher pregnancy success rates. It is projected that IVF treatments in India will be driven by decreased costs, a looser fertility regulation, and an increased age restriction. Moreover, people choose to fly to Asia, where donor egg IVF is permitted, while donor egg IVF services are not offered in certain nations, such as Germany and Italy. As a result, patients choose less expensive fertility destinations, opening up opportunities for expansion for the Asia-Pacific IVF services industry.

However, the use of IVF services is restricted by side effects of the therapy, such as multiple pregnancies and birth problems. The number of embryos transferred determines the success percentage of IVF and can result in multiple pregnancies. Multiple pregnancies can lead to difficulties such as high blood pressure and delivery-related issues. Additionally, a kid may experience a number of health issues as a result of numerous pregnancies, including low birth weight and early delivery. Furthermore, ectopic pregnancy—a condition in which the embryo implants outside of the woman's womb and poses a threat to her life—is another possible risk of IVF treatment. These issues restrict the uptake of IVF operations, which impedes the expansion of the market.





Market Competitive Landscape
In vitro fertilisation (IVF) clinics, technology companies, and healthcare providers of all stripes compete in the Asia-Pacific IVF market by providing IVF services and solutions. The major key players in the Asia-Pacific In-Vitro Fertilization (IVF) Market are: Alcon, Bausch Health Companies Inc., Carl Zeiss AG, Cooper Companies, Johnson & Johnson, MaxiVision Eye Hospital, Rayner Surgical Group Limited, Schwind eye-tech-solutions GmbH & co.kg., STAAR Surgical Company, Ziemer Group AG, Others. A number of variables, including success rates, available technology, cost, and patient experience, influence competition.

Scope of the Report:
 Report Metric Details
 Market size available for years 2019-2033
 Base year considered 2022
 Forecast period 2023-2033
 Segments coveredBy Cycle Type, By End User
 Regions covered
Australia, China, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Thailand, Vietnam, Rest of Asia-Pacific
 Companies CoveredAlcon, Bausch Health Companies Inc., Carl Zeiss AG, Cooper Companies, Johnson & Johnson, MaxiVision Eye Hospital, Rayner Surgical Group Limited, Schwind eye-tech-solutions GmbH & co.kg., STAAR Surgical Company, Ziemer Group AG, Others
COVID-19 Impact on Asia-Pacific In-Vitro Fertilization (IVF) Market
The Asia-Pacific IVF services industry is expected to grow more slowly as a result of the COVID-19 pandemic. Numerous nations implemented lockdowns at the national level, which had a direct effect on fertility tourism as a result of aircraft delays, travel restrictions and quarantines, cancellation of all indoor and outdoor events, and emergency declarations. A great deal of clinics and hospitals underwent structural changes in order to accommodate more COVID-19 patients. Due to doctors' direct interaction with patients seeking IVF therapy, non-urgent patient visits to fertility clinics were discouraged, and elective fertility treatments were delayed. These elements therefore caused the cancellation of numerous planned IVF treatments and were predicted to impede the expansion of the Asia-Pacific IVF market throughout the pandemic.

Key Target Audience
  • Fertility Clinics and Centers
  • Pharmaceutical Companies
  • Medical Device Manufacturers
  • Hospitals and Clinics
  • Research Institutions
  • Others
Our in-depth analysis of the Asia-Pacific In-Vitro Fertilization (IVF) Market includes the following segments:
By Cycle Type:
  • Donor Egg IVF Cycle
  • Fresh Cycle (Non-Donor)
  • Thawed IVF Cycle (Non-Donor)
  • By End User:
  • Clinical Research Institutes
  • Fertility Clinics
  • Hospitals
  • Surgical Centers
  • By Region:
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Myanmar
  • New Zealand
  • Philippines
  • Singapore
  • South Korea
  • Thailand
  • Vietnam
  • Rest of Asia-Pacific
  • Key Topics Covered in the Report
    • Asia-Pacific In-Vitro Fertilization (IVF) Market Size (FY’2023-FY’2033)
    • Overview of Asia-Pacific In-Vitro Fertilization (IVF) Market
    • Segmentation of Asia-Pacific In-Vitro Fertilization (IVF) Market By Cycle Type (Donor Egg IVF Cycle, Fresh Cycle, Thawed IVF Cycle)
    • Segmentation of Asia-Pacific In-Vitro Fertilization (IVF) Market By End User (Clinical Research Institutes, Fertility Clinics, Hospitals, Surgical Centers)
    • Statistical Snap of Asia-Pacific In-Vitro Fertilization (IVF) Market 
    • Expansion Analysis of Asia-Pacific In-Vitro Fertilization (IVF) Market 
    • Problems and Obstacles in Asia-Pacific In-Vitro Fertilization (IVF) Market
    • Competitive Landscape in the Asia-Pacific In-Vitro Fertilization (IVF) Market
    • Impact of COVID-19 and Demonetization on Asia-Pacific In-Vitro Fertilization (IVF) Market 
    • Details on Current Investment in Asia-Pacific In-Vitro Fertilization (IVF) Market
    • Competitive Analysis of Asia-Pacific In-Vitro Fertilization (IVF) Market 
    • Prominent Players in the Asia-Pacific In-Vitro Fertilization (IVF) Market 
    • SWOT Analysis of Asia-Pacific In-Vitro Fertilization (IVF) Market 
    • Asia-Pacific In-Vitro Fertilization (IVF) Market Future Outlook and Projections (FY’2023-FY’2033)
    • Recommendations from Analyst
    1. Introduction
    1.1. Scope of the report
    1.2. Market segment analysis

    2. Research Methodology
    2.1. Research data source
    2.1.1. Secondary Data
    2.1.2. Primary Data
    2.1.3. SPER’s internal database
    2.1.4. Premium insight from KOL’s
    2.2. Market size estimation
    2.2.1. Top-down and Bottom-up approach
    2.3. Data triangulation

    3. Executive Summary

    4. Market Dynamics
    4.1. Driver, Restraint, Opportunity and Challenges analysis
    4.1.1. Drivers
    4.1.2. Restraints
    4.1.3. Opportunities
    4.1.4. Challenges
    4.2. COVID-19 Impacts of the Asia-Pacific In-Vitro Fertilization (IVF) Market 

    5. Market variable and outlook
    5.1. SWOT Analysis
    5.1.1. Strengths
    5.1.2. Weaknesses
    5.1.3. Opportunities
    5.1.4. Threats
    5.2. PESTEL Analysis
    5.2.1. Political Landscape
    5.2.2. Economic Landscape
    5.2.3. Social Landscape
    5.2.4. Technological Landscape
    5.2.5. Environmental Landscape
    5.2.6. Legal Landscape
    5.3. PORTER’s Five Forces 
    5.3.1. Bargaining power of suppliers
    5.3.2. Bargaining power of buyers
    5.3.3. Threat of Substitute
    5.3.4. Threat of new entrant
    5.3.5. Competitive rivalry
    5.4. Heat Map Analysis

    6. Competitive Landscape
    6.1. Asia-Pacific In-Vitro Fertilization (IVF) Market Manufacturing Base Distribution, Sales Area, Product Type 
    6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Asia-Pacific In-Vitro Fertilization (IVF) Market 

    7. Asia-Pacific In-Vitro Fertilization (IVF) Market, By Cycle Type (USD Million)
    7.1. Asia-Pacific In-Vitro Fertilization (IVF) Market Value Share and Forecast, By Cycle Type, 2023-2033
    7.2. Donor Egg IVF Cycle
    7.3. Fresh Cycle (Non-Donor)
    7.4. Thawed IVF Cycle (Non-Donor)

    8. Asia-Pacific In-Vitro Fertilization (IVF) Market, By End User (USD Million)
    8.1. Asia-Pacific In-Vitro Fertilization (IVF) Market Value Share and Forecast, By End User, 2023-2033
    8.2. Clinical Research Institutes 
    8.3. Fertility Clinics
    8.4. Hospitals
    8.5. Surgical Centers

    9. Asia-Pacific In-Vitro Fertilization (IVF) Market Forecast, 2019-2033 (USD Million)
    9.1. Asia-Pacific In-Vitro Fertilization (IVF) Market Size and Market Share

    10. Asia-Pacific In-Vitro Fertilization (IVF) Market, By Cycle Type, 2019-2033 (USD Million)
    10.1. Asia-Pacific In-Vitro Fertilization (IVF) Market Size and Market Share By Cycle Type (2019-2026)
    10.2. Asia-Pacific In-Vitro Fertilization (IVF) Market Size and Market Share By Cycle Type (2027-2033)

    11. Asia-Pacific In-Vitro Fertilization (IVF) Market, By End User, 2019-2033 (USD Million)
    11.1. Asia-Pacific In-Vitro Fertilization (IVF) Market Size and Market Share By End User (2019-2026)
    11.2. Asia-Pacific In-Vitro Fertilization (IVF) Market Size and Market Share By End User (2027-2033)

    12. Asia-Pacific In-Vitro Fertilization (IVF) Market, By Region, 2019-2033 (USD Million)
    12.1. Asia-Pacific In-Vitro Fertilization (IVF) Market Size and Market Share By Region (2019-2026)
    12.2. Asia-Pacific In-Vitro Fertilization (IVF) Market Size and Market Share By Region (2027-2033)
    12.3. Australia
    12.4. China
    12.5. India
    12.6. Indonesia
    12.7. Japan
    12.8. Malaysia
    12.9. Myanmar
    12.10. New Zealand
    12.11. Philippines
    12.12. Singapore
    12.13. South Korea
    12.14. Thailand
    12.15. Vietnam
    12.16. Rest of Asia-Pacific

    13. Company Profile
    13.1. Alcon
    13.1.1. Company details
    13.1.2. Financial outlook
    13.1.3. Product summary 
    13.1.4. Recent developments
    13.2. Bausch Health Companies Inc.
    13.2.1. Company details
    13.2.2. Financial outlook
    13.2.3. Product summary 
    13.2.4. Recent developments
    13.3. Carl Zeiss AG
    13.3.1. Company details
    13.3.2. Financial outlook
    13.3.3. Product summary 
    13.3.4. Recent developments
    13.4. Cooper Companies
    13.4.1. Company details
    13.4.2. Financial outlook
    13.4.3. Product summary 
    13.4.4. Recent developments
    13.5. Johnson & Johnson
    13.5.1. Company details
    13.5.2. Financial outlook
    13.5.3. Product summary 
    13.5.4. Recent developments
    13.6. MaxiVision Eye Hospital
    13.6.1. Company details
    13.6.2. Financial outlook
    13.6.3. Product summary 
    13.6.4. Recent developments
    13.7. Rayner Surgical Group Limited
    13.7.1. Company details
    13.7.2. Financial outlook
    13.7.3. Product summary 
    13.7.4. Recent developments
    13.8. Schwind eye-tech-solutions GmbH & co.kg.
    13.8.1. Company details
    13.8.2. Financial outlook
    13.8.3. Product summary 
    13.8.4. Recent developments
    13.9. STAAR Surgical Company
    13.9.1. Company details
    13.9.2. Financial outlook
    13.9.3. Product summary 
    13.9.4. Recent developments
    13.10. Ziemer Group AG
    13.10.1. Company details
    13.10.2. Financial outlook
    13.10.3. Product summary 
    13.10.4. Recent developments
    13.11. Others 
     
    14. List of Abbreviations

    15. Reference Links

    16. Conclusion

    17. Research Scope

    SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

    The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings.  The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

    SPER-Methodology-1

    SPER-Methodology-2

    SPER-Methodology-3


    Frequently Asked Questions About This Report
    Asia-Pacific In-Vitro Fertilization (IVF) Market is projected to reach USD 63.52 billion by 2033, growing at a CAGR of 17.24% during the forecast period.
    Asia-Pacific In-Vitro Fertilization (IVF) Market grew in Market size from 2022. The Market is expected to reach USD 63.52 billion by 2033, at a CAGR of 17.24% during the forecast period.
    Asia-Pacific In-Vitro Fertilization (IVF) Market CAGR of 17.24% during the forecast period.
    Asia-Pacific In-Vitro Fertilization (IVF) Market size is USD 63.52 billion from 2023 to 2033.
    Asia-Pacific In-Vitro Fertilization (IVF) Market Segment is covered By Cycle Type, By End User.
    The Asia-Pacific is anticipated to have the highest Market share in the Asia-Pacific In-Vitro Fertilization (IVF) Market.
    The key players in the Market include Companies Covered Alcon, Bausch Health Companies Inc., Carl Zeiss AG, Cooper Companies, Johnson & Johnson, MaxiVision Eye Hospital, Rayner Surgical Group Limited, Schwind eye-tech-solutions GmbH & co.kg., STAAR Surgical Company, Ziemer Group AG, Others.
    An assisted reproductive technology (ART) process called in vitro fertilisation (IVF) involves fertilising egg cells with sperm outside of the woman's body and then implantation of the resulting embryo(s) into the uterus.
    Not able to find what you are looking for? Need customization in the existing report?
    Click Here

    Join Our SPER Panel

    Our Global Clients

    Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
    SPER-Astellas Pharma
    SPER-Citi Bank
    SPER-Microsoft
    SPER-EY
    SPER-Sanofi
    SPER-p&g
    SPER-Johnson & Johnson
    SPER-SIEMENS
    SPER-LOREAL
    SPER-Pfizer
    SPER-IPSOS
    SPER-Heineken
    SPER-IQVIA
    SPER-Kankar IMRB
    SPER-PWC
    SPER-Astellas Pharma
    SPER-Citi Bank
    SPER-Microsoft
    SPER-EY
    SPER-Sanofi
    SPER-p&g
    SPER-Johnson & Johnson
    SPER-SIEMENS
    SPER-LOREAL
    SPER-Pfizer
    SPER-IPSOS
    SPER-Heineken
    SPER-IQVIA
    SPER-Kankar IMRB
    SPER-PWC

    SPER

    Market Research

    We are the leading, full-service global market research and consulting company.

    Certificates
    iso-1 iso-1 iso-1 ESOMAR
    Secure Payments
    SPER Payment Options
    Contact HR

     [email protected]

     +91-742-898-5650